MARKET

VCYT

VCYT

Veracyte
NASDAQ
20.80
-0.04
-0.19%
After Hours: 21.13 +0.33 +1.59% 17:30 05/24 EDT
OPEN
21.06
PREV CLOSE
20.84
HIGH
21.07
LOW
20.71
VOLUME
460.68K
TURNOVER
0
52 WEEK HIGH
30.52
52 WEEK LOW
18.61
MARKET CAP
1.59B
P/E (TTM)
-22.2555
1D
5D
1M
3M
1Y
5Y
4 Must-Buy Efficient Stocks to Enrich Your Portfolio
NASDAQ · 2d ago
Veracyte's (VCYT) New Findings to Advance Thyroid Cancer Care
NASDAQ · 3d ago
Buy 5 Medical Instruments Stocks to Enhance Your Portfolio
NASDAQ · 3d ago
Veracyte (VCYT) Up 6% Since Last Earnings: Will it Continue?
NASDAQ · 5d ago
Weekly Report: what happened at VCYT last week (0513-0517)?
Weekly Report · 6d ago
Veracyte to Participate in Upcoming Investor Conferences
Veracyte, Inc. A leading cancer diagnostics company, will participate in the following investor conferences. Veracyte will present at the Leerink Partners 2024 Healthcare Crossroads Conference and the William Blair 44th Annual Growth Stock Conference. Live audio webcasts of the company’s presentations will be available at veracyte's website.
Barchart · 05/15 16:04
Wall Street Analysts Believe Veracyte (VCYT) Could Rally 39.59%: Here's is How to Trade
NASDAQ · 05/13 13:55
Weekly Report: what happened at VCYT last week (0506-0510)?
Weekly Report · 05/13 10:09
More
About VCYT
Veracyte, Inc. is a global diagnostics company. The Company enables clinicians with insights they need to guide and assure patients. The Company offers tests for thyroid cancer (Afirma), prostate cancer (Decipher Prostate), breast cancer (Prosigna), interstitial lung diseases (Envisia), and bladder cancer (Decipher Bladder). Its Percepta Nasal Swab test is being run in its Clinical Laboratory Improvement Amendments (CLIA) lab in support of clinical studies and its tests for kidney cancer and lymphoma are in development, the latter as a companion diagnostic. Its products consist of the Prosigna breast cancer assay, the nCounter Analysis System, related diagnostic kits, and services. In the United States, it offers laboratory developed tests (LDTs), through its CLIA labs in South San Francisco and San Diego, California, supported by its cytopathology know-how in Austin, Texas. The Company also offers whole-genome MRD platform that enable it in early cancer diagnosis and risk assessment.

Webull offers Veracyte Inc stock information, including NASDAQ: VCYT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VCYT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VCYT stock methods without spending real money on the virtual paper trading platform.